MedTrace Logo

MyoSense- Automated Muscle Hypertonicity Classification System

NCT02076581 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2015-06-01

No results posted yet for this study

Summary

It is often difficult to quantify and distinguish aspects of abnormal muscle tone due to neurological injury. This makes it difficult to evaluate therapies that aim to reduce the effects of abnormal muscle tone. This research study will evaluate the feasibility of a clinician worn device to capture and quantify features of spasticity and dystonia.

Conditions

  • Stroke
  • Dystonia
  • Cerebral Palsy

Sponsors & Collaborators

  • The Cleveland Clinic

    collaborator OTHER

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Great Lakes NeuroTechnologies Inc.

    lead INDUSTRY

Principal Investigators

  • Joseph P Giuffrida, PhD · Great Lakes NeuroTechnologies Inc.

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02076581 on ClinicalTrials.gov